(Q45330756)

English

A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder

scientific article published on 24 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder (English)

1 reference

Europe PubMed Central

13 December 2017

0 references

post-traumatic stress disorder

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Y Panahi

1

1 reference

Europe PubMed Central

13 December 2017

B Rezazadeh Moghaddam

2

1 reference

Europe PubMed Central

13 December 2017

A Sahebkar

3

1 reference

Europe PubMed Central

13 December 2017

M Abbasi Nazari

4

1 reference

Europe PubMed Central

13 December 2017

F Beiraghdar

5

1 reference

Europe PubMed Central

13 December 2017

G Karami

6

1 reference

Europe PubMed Central

13 December 2017

A R Saadat

7

1 reference

Europe PubMed Central

13 December 2017

language of work or name

0 references

publication date

24 February 2011

1 reference

Europe PubMed Central

13 December 2017

Psychological Medicine

1 reference

Europe PubMed Central

13 December 2017

41

1 reference

Europe PubMed Central

13 December 2017

2159-2166

1 reference

Europe PubMed Central

13 December 2017

10

1 reference

Europe PubMed Central

13 December 2017

Posttraumatic stress disorder and functioning and quality of life outcomes in a nationally representative sample of male Vietnam veterans

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Drug treatment for PTSD. Answers and questions

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Fluvoxamine treatment for chronic PTSD: a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-being

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Electrocardiogram abnormalities among men with stress-related psychiatric disorders: implications for coronary heart disease and clinical research.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Posttraumatic stress disorder in the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

What is a "mood stabilizer"? An evidence-based response

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

21 January 2018

Post-traumatic stress disorder in the community: an epidemiological study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoxetine versus placebo in posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women

1 reference

https://api.crossref.org/works/10.1017%2FS0033291711000201

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0033291711000201

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45330756&oldid=2074697563"